CSR ADR Reporting Careers Media Contact Us Site Map Blog Search for: About us Vision & Mission Core Values Milestones Leadership Chairman and Managing Director Founder Chairman Corporate Social Responsibility (CSR) Corporate Governance Corporate Governance Manual Code of Conduct Audit Committee Charter Compliance Committee Profile of Directors Policies Vigil Mechanism Risk Management Policy PSH at workplace Businesses Contract Research Operation Contract Manufacturing Herbal Division – Chezgreen Agro Division Group Companies Products API Formulations RESEARCH Alliances Champion Brands Life @Cadila Pharma Foundation Day Navratri Celebrations Employee Engagements International Women’s Day Christmas Birthday Brand fest For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza Download in PDF format Formulations A wide array of more than 850 products to meet most unmet medical needs, catering to a vast and diverse therapeutic portfolio Read >> Download in PDF format API More than 38 APIs and intermediates including USFDA – certified products are manufactured at our ISO-9002 & ISO14001 accredited facilities at Ankleshwar, India Read >> Download in PDF format Innovation Innovative products like ‘Polycap’ for cardiovascular disease, Risorine for Tuberculosis and Mycidac –C for lung cancer have been developed inhouse Read >> Download in PDF format Manufacturing Three state of the art manufacturing facilities in the state of Gujarat, Jammu (India) and Ethiopia are approved by all prominent international regulatory bodies, including USFDA Read >> The public at large is cautioned of fraudulent activities and false commitments using the name of Cadila. Disclaimer Public at large are hereby cautioned about fraudulent activities and false commitments inviting general public at large to deposit/invest funds with trust associated investment activities carried out with malicious intent in the name of CADILA by using deceptive stationary like letterhead, round stamp and thereby wrongly misleading the public at large. Such activities are carried out by some group of fraudsters with an intention to cheat under wrongful commitment and allurement. Therefore, CADILA advises the general public to not take the bait and avoid giving their confidential details or money to such false/fabricated commitments. CADILA is not involved in such fraudulent activities and hence is not liable, responsible or answerable in case of any financial deception. CADILA shall not entertain, answer or attend any such fraudulent claims thereunder if any. About us Download in PDF format Cadila Pharmaceuticals Limited, established in 1951 is one of the largest privately held pharmaceutical companies in India. An innovation and research focused company, we have been developing, manufacturing, selling and distributing pharmaceutical products across more than 45 therapeutic areas Read >> OUR INSPIRATION Download in PDF format Mr. Indravadan A. Modi, Founder Chairman of Cadila Pharmaceuticals is called the Medicine Man of India. He was also the Champion of Indian Patents Act, 1970. He believed in making medicine affordable to the last man in the society. Read >> GLOBAL PRESENCE Download in PDF format Cadila Pharmaceuticals with a significant presence in over 90 countries has a multicultural, multilingual and multinational workforce of more than 7000 employees including over two hundred people outside India in Africa, CIS, Japan and USA Read >> Get in touch CSR Careers Media Contact Us Site Map CPL Biologicals Karnavati Engineering IAMICON Agro CRO Counterfeit Drugs: In case of any information on /or availability of counterfeit products... Read More © 2018 Cadila Pharmaceuticals all right reserved Corporate identification No : U24231GJ1991PLC015132 {"popup_ID":18390,"when_popup_appear":"page_load","delay":"2","x_second":"","x_scroll":"4","disappear":"","exptime":"0","hideclsbtn":"","clsonesc":"1"} Drug counterfeiting is a serious offence worldwide and claims many lives every year, while jeopardizing the lives of others. Today, counterfeiters are increasingly employing deceitful tactics to lure people with cheaper, but fatal drugs. Typically, counterfeiting today employs many mechanisms viz. absence of active ingredient, low levels of active ingredient, replacing safe drugs with poor-quality drugs and wrong packaging. As a responsible corporate house, Cadila Pharmaceuticals Limited has started a drive against infringement or counterfeiting of its products. In this journey we urge you all to join and support us by reporting any type of counterfeiting of any of our products. You can mail us at website@cadilapharma.co.in or call us on +91 - 2718 - 225001 and provide the details of the product mentioned below. Product Name Batch number of the product Location where such issue found Retailers/Whole Seller address and details Indications that product has been counterfeited Please mail picture/document facility and provide your contact details. Cadila Pharmaceuticals